Skip to main content

Insulet Corporation ratios

  • PODD · Nasdaq
  • Medical devices
  • Health Care Equipment
  • S&P 500
$152.48+2.14%Close 13 Nov 2026 · Market value $10.12B

In fiscal 2025 (the year to 31 Dec 2025), Insulet Corporation had an operating margin of 17.5%, a return on equity of 18.1%, a return on invested capital of 19.5%.

From Insulet Corporation's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025.

Annual

Insulet Corporation ratios, annual
USDFY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Gross margin27.7%45.1%43.8%43.7%45.5%55.0%50.5%57.5%59.8%65.7%65.1%64.4%68.4%61.7%68.3%69.8%71.6%
Operating margin−89.9%−39.8%−27.9%−17.0%−11.8%−3.8%−18.5%−2.9%−1.6%4.9%6.8%5.7%11.5%2.9%13.0%14.9%17.5%
Net margin−110%−63.1%−30.1%−24.5%−18.2%−22.3%−27.9%−7.9%−5.8%0.6%1.6%0.8%1.5%0.4%12.2%20.2%9.1%
Free cash flow margin−79.5%−43.5%−24.0%−18.9%−1.6%−1.1%−8.8%−1.7%−7.0%−21.6%−8.8%−5.0%−16.4%−0.3%4.1%14.7%13.9%
Return on equity−117%−95.5%−61.5%−81.7%−53.3%−49.4%−125%−59.4%−24.2%1.8%8.1%2.0%2.9%0.9%34.1%43.0%18.1%
Return on assets—−19.5%−17.8%−13.6%−9.5%−2.4%−13.5%−2.3%−0.9%2.0%3.9%2.4%5.3%0.8%8.7%8.6%11.0%
Return on capital employed—−28.1%−25.7%−21.0%−14.7%−3.6%−21.1%−3.5%−1.3%3.5%5.6%3.9%7.2%2.0%10.9%13.2%18.7%
Return on invested capital—−108%−51.5%−26.5%−22.0%−7.0%−39.9%−8.7%−2.9%4.2%7.0%5.3%11.5%1.5%15.3%15.1%19.5%
Current ratio—7.524.742.284.684.702.936.646.243.993.756.015.813.603.513.582.81
Debt to equity—1.051.312.670.911.965.045.273.572.7911.941.782.313.011.981.170.66
Net debt / EBITDA—————3.83—10.9319.407.056.801.202.627.372.541.200.51
Interest coverage−4.49−1.70−2.89−2.19−1.73−0.61−3.83−0.74−0.300.951.451.072.041.046.087.237.98
Cash conversion72.5%69.0%79.8%77.2%8.8%5.0%31.5%21.5%121%−3682%−563%−662%−1071%−84.8%34.0%73.0%153%
SBC / Revenue6.4%5.2%5.1%4.7%5.1%9.7%7.3%6.4%6.9%6.7%3.9%4.0%3.1%3.1%2.9%3.3%2.3%

Quarterly

Insulet Corporation ratios, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Gross margin70.9%69.5%67.7%69.3%72.1%71.9%69.7%72.2%72.5%69.5%70.2%75.1%
Operating margin20.9%12.9%11.2%16.2%18.3%15.6%18.7%16.7%18.7%16.0%16.2%22.5%
Net margin20.3%11.7%38.6%14.2%16.9%6.2%3.5%12.4%13.0%12.0%11.8%16.8%
Free cash flow margin3.1%14.8%13.2%15.0%15.7%9.1%27.4%14.2%6.1%11.8%7.0%7.9%
Return on equity14.1%6.5%18.9%6.9%8.3%2.7%1.5%6.3%6.7%7.0%6.7%8.9%
Return on assets3.9%2.0%1.5%2.7%3.2%1.9%2.8%2.8%3.3%3.3%3.3%4.4%
Return on capital employed5.0%2.6%2.3%3.5%4.3%3.0%4.9%4.9%5.8%5.3%5.4%7.3%
Return on invested capital6.7%3.5%2.6%4.8%5.8%3.6%5.3%4.9%5.8%5.3%5.4%7.4%
Current ratio3.513.743.603.683.584.472.262.872.812.492.482.51
Debt to equity1.981.771.401.251.171.270.960.730.660.730.670.61
Net debt / EBITDA5.948.597.834.533.583.731.941.841.673.152.641.73
Interest coverage15.905.324.957.1012.719.656.187.549.828.319.6111.72
Cash conversion15.4%127%34.1%105%93.3%145%791%114%47.4%98.2%58.8%47.1%
SBC / Revenue2.5%3.2%3.5%3.3%3.3%3.2%1.2%2.4%2.6%2.8%2.4%2.4%

The main figures as JSON and plain text. See data and methodology.

PODD in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.